Navigation Links
Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin
Date:4/10/2008

CHICAGO, April 10 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), today announced that, based on a productive meeting with the U.S. Food and Drug Administration (FDA), the Company plans to submit a New Drug Application (NDA) in the third quarter of 2008 for its novel once-a-day oral antibiotic, cethromycin, to treat mild-to-moderate community acquired pneumonia (CAP).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

"We are pleased with the outcome of the meeting because it allows us to remain on track with our NDA submission goal," said Dr. Michael T. Flavin, chief executive officer of Advanced Life Sciences. "In addition, we believe that achieving this milestone will enable our partnership discussions to continue toward a conclusion in a timely manner."

During the meeting, FDA officials agreed that the Company could submit the NDA for cethromycin to treat mild-to-moderate CAP based on the pivotal Phase 3 trial results previously reported. The FDA will review any submission the Company makes to determine whether it meets the requirements for filing. There can be no assurance that the FDA will file the NDA, or that once filed, it will be approved.

Conference Call Details

The Company will host a conference call and live webcast today, Thursday, April 10, 2008, at 8:30 am (EDT). The focus of the call will be to discuss the planned NDA submission for the Company's novel once-a-day oral antibiotic, cethromycin, as a treatment for mild-to-moderate CAP.

The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of the Advanced
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2008)...Newswire-FirstCall/ -- Cell Therapeutics, Inc.,(CT...sent at three upcoming,investor conferences. The c...um in San Francisco in October, the 19th Annual Op... Annual Acumen BioFin Rodman & Renshaw,Healthcare ...he presentations will be webcast live with slides,...
(Date:10/10/2008)...Newswire-FirstCall/ -- Cell Therapeutics, Inc.,(CT... Company intends to,request a hearing with the NAS... for regaining compliance with NASDAQ Marketplace ...t value of listed securities of $50 million.,CTI r...AQ Stock Market LLC,on October 7, 2008 indicating ...
(Date:10/10/2008)... academia and industry reveal powerful effects of,... mammalian cell culture leading to a si...olo., Oct. 10 /- A recently published... & Developmental Biology,revealed that recombinant....Lacromin.com ) is a strong growth factor for prom...
(Date:10/10/2008)...10 /- Boston Scientific,Cor...ived approval from the,U.S. Food and Drug Administ...(R) Liberte(R) Paclitaxel-Eluting Coronary Stent S...te stent early next month in the United,States, fo...S(R),Expresss2(TM) Atom(TM) Paclitaxel-Eluting Cor...
Breaking Biology Technology:Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences 2Cell Therapeutics to Request a Hearing With NASDAQ Following Receipt of Staff Determination Letter 2Cell Therapeutics to Request a Hearing With NASDAQ Following Receipt of Staff Determination Letter 3New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture 2Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 2Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 3
... BIO 03. Lets take a walking tour through the futu... Pavilion in the cavernous exhibit hall at the Was... the anniversary Harley-Davidson motorcycle parked... with biotechnology, but its a great way to lure p...y today to deliver what he characterized as a Knut...
...l has published the first-ever magazine about Wisc...tion highlights the states research base, technolo...life, key contacts and the I-Q Corridor that joins...The Wisconsin Technology Network has arranged to p...art Choice, over the next few weeks. Today we pres...
...urely be a quixotic quest for the perfect mobile h... best designs from Plantronics, Shure, and Etymoti...eat strengths and a few tradeoffs, usually in the ...luetooth wireless headset from a newcomer to the m...ing and comfort. The Pittsburgh-based company seem...
...major advantages , ,MADISON, Wis. Wisconsins bio...t thanks to feature appearing in the June issue of...consins growing biotech clusters in Madison and Mi... factors, including the states colleges and univer..., local and state government initiatives and lifes...
Other Biology Technology:On Location at BIO 2003 2Life Science: From the arts to the outdoors: Living and Playing in Wisconsin 2Life Science: From the arts to the outdoors: Living and Playing in Wisconsin 3Life Science: From the arts to the outdoors: Living and Playing in Wisconsin 4Life Science: From the arts to the outdoors: Living and Playing in Wisconsin 5The quest for the perfect headset 2The quest for the perfect headset 3Wisconsin biotech sector featured in scientific magazine 2Wisconsin biotech sector featured in scientific magazine 3
(Date:10/10/2008)...ya Yamanaka MD, PhD, of Kyoto University and the G...) has taken another step forward in improving the ...uced pluripotent stem (iPS) cell technology. , P... can be reprogrammed to become embryonic stem cell... four genes required to reprogram the cells, and a...
(Date:10/10/2008)...archers from the Peninsula Medical School in Plymo...he one hour of moderate exercise a day recommended... to tackle the rising problem of childhood obesity...t recent issue of the journal "Archives of Disease...lyBird study, which has followed the development o...
(Date:10/10/2008)...Haven, Conn. Yale scientists have created nanowir...ronics that are both sensitive and specific enough...ion, according to a report in Nano Letters . , ...ly specific antigens signatures of bacteria, viru... are activated, they produce acid, and generate a ...
(Date:10/10/2008)...nancy and motherhood may make us all go a little g... according to mental health researchers at The Aus...ted by the Centre for Mental Health Research (CMHR...have that pregnancy affects their cognitive functi... The findings have been released as part of Mental...
Breaking Biology News(10 mins):Yamanaka eliminates viral vector in stem cell reprogramming 2Recommendations for children's exercise lacking say experts 2Sensitive nanowire disease detectors made by Yale scientists 2Pregnancy not turning minds to mush: Study 2America Faces Critical Shortage of Veterinarians 26779 1America Faces Critical Shortage of Veterinarians 26779 2Debiopharm Moves Towards a New 6 Month Formulation of Decapeptyl 28R 29 to Further Help Prostate Cancer Patients 3152 1Debiopharm Moves Towards a New 6 Month Formulation of Decapeptyl 28R 29 to Further Help Prostate Cancer Patients 3152 2New Site Launched for Families and Scientists to Discuss Stem Cell Research 28US 29 26776 1New Site Launched for Families and Scientists to Discuss Stem Cell Research 28US 29 26776 2Urgent Care Provider NextCare Opens First Immediate Care Clinic in Texas 26773 1Urgent Care Provider NextCare Opens First Immediate Care Clinic in Texas 26773 2
...ming Quarterly Review of Biology, biologists from ... distinct types of laughter ?laughter which is sti...and strategic. , "Laughter that occurs during eve...ents and humorless conversation is now being studi... "The unstated issue is whether such laughter is s...
...arth,s landscape , The ice ages made massive chan...ng below the ice in the oceans? , Research by mari...estruction as whole communities of animals were wi...n the past it has been thought that these ecosyste...nearby habitats that escaped obliteration. But res...
...t study in Science , More than 100 scientists fro...bing the genome of the mouse in a joint study last...ave completely overturned geneticists, traditional...estigious journal Science on 2nd September. The ge...f mammals is much more complex than was hitherto s...
...n carry and spread to humans is the focus of resea...versity distinguished professor of biochemistry an...archers in his lab are studying how insects protec...wer lies in insects, blood, specifically proteins....nding which molecules are present in the blood and...
Other Biology News:Gene therapy may protect normal tissues during radiation retreatment for lung cancer 2Mouse genome much more complex than expected 2K-State researchers study insects' immune system 2
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies.
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)
PP2B-Abeta (C-20)
... intensely fluorescent and highly photostable Fluo...se in a variety of applications requiring probes t...otein- and other macromolecule-labeled microsphere...bind to non-target surfaces in some applications. ...
Biology Products: